UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 201

Sortiert nach

Induction of Humoral Immune Responses following Vaccination with Envelope-Containing, Formaldehyde-Treated, Thermally Inactivated Human Immunodeficiency Virus Type 1

Journal of Virology, 2005-04, Vol.79 (8), p.4927-4935

2005

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the V1 domain of Thai CRF01-AE viruses that confer sensitivity/resistance to broadly neutralizing antibodies

Retrovirology, 2012-09, Vol.9 (S2), p.P106-P106, Article P106

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel vomputational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies

Retrovirology, 2012-09, Vol.9 (Suppl 2), p.P353-P353

2012

Link zum Volltext

Verfügbarkeit prüfen

P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P390-P390, Article P390

2009

Link zum Volltext

Verfügbarkeit prüfen

P05-14 LB. Analysis of virus swarms to identify vaccine immunogens with improved exposure of epitopes recognized by broadly neutralizing antibodies

Retrovirology, 2009-10, Vol.6 (S3), p.P396-P396, Article P396

2009

Link zum Volltext

Verfügbarkeit prüfen

P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P395-P395, Article P395

2009

Link zum Volltext

Verfügbarkeit prüfen

P04-47. High-titer autologous and heterologous neutralizing antibody activity in acute SIV-infection

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P75-P75, Article P75

2009

Link zum Volltext

Verfügbarkeit prüfen

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.O6-O6, Article O6

2009

Link zum Volltext

Verfügbarkeit prüfen

P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P46-P46, Article P46

2009

Link zum Volltext

Verfügbarkeit prüfen

Rapid Evolution of the Neutralizing Antibody Response to HIV Type 1 Infection

Proceedings of the National Academy of Sciences - PNAS, 2003-04, Vol.100 (7), p.4144-4149

2003

Link zum Volltext

Verfügbarkeit prüfen

P04-03. Cross-clade neutralization analysis of plasmas from clade B, C and CRF01_AE HIV-infected donors

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P31-P31, Article P31

2009

Link zum Volltext

Verfügbarkeit prüfen

Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated

Journal of Virology, 1994-03, Vol.68 (3), p.1342-1349

1994

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

Journal of Virology, 2004-12, Vol.78 (23), p.13232-13252

2004

Link zum Volltext

Verfügbarkeit prüfen

Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera

Journal of Virology, 1995-01, Vol.69 (1), p.39-48

1995

Link zum Volltext

Verfügbarkeit prüfen

The prevalence of antiretroviral drug resistance in the United States

AIDS (London), 2004-07, Vol.18 (10), p.1393-1401

2004

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing Antibody Responses Drive the Evolution of Human Immunodeficiency Virus Type 1 Envelope during Recent HIV Infection

Proceedings of the National Academy of Sciences - PNAS, 2005-12, Vol.102 (51), p.18514-18519

2005

Link zum Volltext

Verfügbarkeit prüfen

International network for comparison of HIV neutralization assays : the NeutNet report

PloS one, 2009-02, Vol.4 (2), p.e4505-e4505

2009

Link zum Volltext

Verfügbarkeit prüfen

Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1

Journal of Virology, 2003-10, Vol.77 (19), p.10557-10565

2003

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B

Journal of Virology, 2005-05, Vol.79 (10), p.6523-6527

2005

Link zum Volltext

Verfügbarkeit prüfen

Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia

The New England journal of medicine, 2001-02, Vol.344 (7), p.472-480

2001

Link zum Volltext

Verfügbarkeit prüfen

International network for comparison of HIV neutralization assays: the NeutNet report II

PloS one, 2012-05, Vol.7 (5), p.e36438-e36438

2012

Link zum Volltext

Verfügbarkeit prüfen

A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

Antimicrobial Agents and Chemotherapy, 2000-04, Vol.44 (4), p.920-928

2000

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity

Virology (New York, N.Y.), 2008-11, Vol.381 (2), p.251-260

2008

Link zum Volltext

Verfügbarkeit prüfen

Molecular Mechanisms of Resistance to Human Immunodeficiency Virus Type 1 with Reverse Transcriptase Mutations K65R and K65R+M184V and Their Effects on Enzyme Function and Viral Replication Capacity

Antimicrobial Agents and Chemotherapy, 2002-11, Vol.46 (11), p.3437-3446

2002

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis

Virology (New York, N.Y.), 2007-08, Vol.364 (2), p.441-453

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 201

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(194)

Publikationsform

Sprache

Englisch
(199)
Japanisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Humans
(116)
Life Sciences & Biomedicine
(111)
Virology
(72)
Biological And Medical Sciences
(67)
Infectious Diseases
(53)
Human Immunodeficiency Virus 1
(52)
Immunology
(50)
Hiv-1 - Immunology
(49)
Medical Sciences
(49)
Microbiology
(49)
Neutralization Tests
(42)
Hiv Infections - Immunology
(39)
Hiv
(38)
Hiv Infections - Virology
(38)
Male
(38)
Hiv-1 - Genetics
(36)
Human Immunodeficiency Virus
(36)
Viral Diseases
(36)
Fundamental And Applied Biological Sciences. Psychology
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Induction of Humoral Immune Responses following Vaccination with Envelope-Containing, Formaldehyde-Treated, Thermally Inactivated Human Immunodeficiency Virus Type 1

Mutations in the V1 domain of Thai CRF01-AE viruses that confer sensitivity/resistance to broadly neutralizing antibodies

Novel vomputational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies

P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression

P05-14 LB. Analysis of virus swarms to identify vaccine immunogens with improved exposure of epitopes recognized by broadly neutralizing antibodies

P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes

P04-47. High-titer autologous and heterologous neutralizing antibody activity in acute SIV-infection

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target

P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group

Rapid Evolution of the Neutralizing Antibody Response to HIV Type 1 Infection

P04-03. Cross-clade neutralization analysis of plasmas from clade B, C and CRF01_AE HIV-infected donors

Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated

Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera

The prevalence of antiretroviral drug resistance in the United States

Neutralizing Antibody Responses Drive the Evolution of Human Immunodeficiency Virus Type 1 Envelope during Recent HIV Infection

International network for comparison of HIV neutralization assays : the NeutNet report

Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1

Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B

Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia

International network for comparison of HIV neutralization assays: the NeutNet report II

A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity

Molecular Mechanisms of Resistance to Human Immunodeficiency Virus Type 1 with Reverse Transcriptase Mutations K65R and K65R+M184V and Their Effects on Enzyme Function and Viral Replication Capacity

Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis

Suchergebnisse filtern